Egalet-001 neurology data

Data from the first half of a laboratory-based in vitro manipulation and extraction abuse deterrence study showed that oral Egalet-001 was resistant to common methods of physical manipulation, including crushing, cutting or grinding, for purposes of abuse compared to MS Contin morphine sulfate controlled-release oral tablets from Purdue Pharma L.P. (Stamford, Conn.). In the study, an independent laboratory tested a number of electrical and non-electrical household tools in an effort to reduce the particle size of the products for purposes of abuse. The second half of the study will test the capacity to extract the active pharmaceutical ingredient from the product using common household solvents. ...